Welcome to our dedicated page for InfuSystem Holdings news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on InfuSystem Holdings stock.
InfuSystem Holdings, Inc. provides health care services that facilitate outpatient care for durable medical equipment manufacturers and health care providers. News for INFU commonly covers financial results, segment trends and operating updates across Patient Services and Device Solutions, including oncology, pain management, wound therapy, direct payer rentals, pump and consumable sales, and biomedical services and repair.
Company updates also address revenue cycle management, payer-network and billing efficiency initiatives, relationships with DME manufacturers, contract economics, margin performance, cash flow, guidance and management presentations at investor conferences.
InfuSystem will present at the Sidoti Small Cap Virtual Investor Conference on June 12, 2024, at 8:30 a.m. Eastern Time. The conference will feature presentations from CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance. Investors can access the live webcast and replay on InfuSystem's website. Additionally, the management will host virtual one-on-one meetings throughout the day. InfuSystem, based in Rochester Hills, Michigan, provides outpatient care for durable medical equipment through two main platforms: Patient Services and Device Solutions. The company operates several Centers of Excellence in the USA and Canada.
InfuSystem, a national healthcare service provider, announced a $20 million stock repurchase program authorized by its Board of Directors. This program extends through June 30, 2026, and replaces the previous authorization expiring June 30, 2024, under which 550 thousand shares were repurchased for $6.2 million. The new program highlights confidence in the company’s operations, financial strength, and future outlook, allowing flexible share repurchases under favorable conditions. CEO Richard DiIorio emphasized the company’s commitment to strategic investments for sustainable growth while considering opportunistic buybacks.
InfuSystem reported record net revenues of $32.0 million in the first quarter of 2024, representing a 5% growth from the prior year. The gross profit increased by 10%, with a gross margin of 51.5%. Adjusted EBITDA decreased by 9% compared to the prior year. The company's liquidity totaled $45.4 million as of March 31, 2024.
InfuSystem Holdings, Inc. (NYSE American: INFU) will report first quarter 2024 financial results on May 9, 2024. The company will conduct a conference call at 9:00 a.m. Eastern Time to discuss the results. InfuSystem is a leading national health care service provider, offering outpatient care for durable medical equipment manufacturers and health care providers.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.